Product Details for: Imfinzi
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
500MG/10ML (50MG/ML)
Single-Dose Vial
351(a)
Imfinzi
Rx
002
Injection
Intravenous
120MG/2.4ML (50MG/ML)
Single-Dose Vial
351(a)
Imfinzi
Rx
Proper Name
durvalumab
durvalumab
BLA Number
761069
761069
Applicant
AstraZeneca UK Ltd
AstraZeneca UK Ltd
Original Approval Date
May 1, 2017
May 1, 2017
Date of First Licensure